EN PL
ORIGINAL PAPER
Anti-HSP70 antibodies in patients with systemic lupus erythematosus
 
More details
Hide details
 
Online publication date: 2010-04-09
 
 
Reumatologia 2010;48(1):31-36
 
KEYWORDS
ABSTRACT

Aim: The aim of the study was to assess the connection between serum concentration of anti-HSP70 antibodies and early atheromatosis in patients with systemic lupus erythematosus (SLE).
Material and methods: 16 patients with SLE (aged 27-60 years; mean age 44.4 years) and 13 healthy volunteers (aged 24-57 years; mean age 43.1) entered the study. In all subjects intima media thickness (IMT) of carotid arteries and serum concentration of anti-HSP70 antibodies were assessed.
Results: In the SLE group IMT of the common carotid artery, internal carotid artery and bulbs of the carotid artery were bilaterally significantly thicker than in the control group, proving that the arteriosclerosis was more advanced in the SLE group. In the SLE group a statistically significant correlation between IMT and age was found. Apart from this in the SLE group there was a statistically significant negative correlation between mean IMT of the right common carotid artery and HDL concentration (RP = &#8211;0.54, p < 0.05). In the SLE group a correlation between IMT and doses of glucocorticosteroids was found. The difference in concentration of anti-HSP70 antibodies between groups was not significant (116.5 ±188.0 µg/ml vs. 236.3 ±319.5 µg/ml; p > 0.05). In both groups no correlation between IMT and serum concentration of anti-HSP70 antibodies was found.
Conclusions: In our study we did not confirm the correlation between anti-HSP70 antibodies and atheromatosis that was described by other authors.
 
REFERENCES (17)
1.
Bulkley B, Roberts W. The heart in SLE and changes induced init by corticosteroid therapy: a study of 36 necroscopy cases. Am J Med 1975; 53: 243-264.  .
 
2.
Esdaile J, Abrahamowicz M, Grodzicky T, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosous. Arthritis Rheum 2001; 44: 2231-2237.  .
 
3.
Nikpour M, Urowitz M, Gladman D. Premature atherosclerosis In systemic lupus erythematosus. Rheum Dis Clin North Am 2005; 31: 329-359.  .
 
4.
Bruce I, Urowitz M, Gladman D, et al. Risk factors for coronary heart disease in women with systemic lupus erythematosus: The Toronto Risk Factor Study. Arthritis Rheum 2003; 48: 3159-3167.  .
 
5.
Pockley G. Heat shock proteins, inflammation, and cardiovascular disease. Circulation 2002; 105: 1012-1017.  .
 
6.
Xu Q, Wick G, Willeit J, et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet 1993; 341: 255-259.  .
 
7.
Hoppichler F, Lechleitner M, Traweger C, et al. Changes of serum antibodies to heat-shock protein 65 in coronary heart disease and acute myocardial infarction. Atherosclerosis 1996; 126: 333-338.  .
 
8.
Zhu J, Quyyumi A, Rott D, et al. Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease. Evidence for an autoimmune component of atherogenesis. Circulation 2001; 103: 1071-1075.  .
 
9.
Tan E, Cohen A, Fries J, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277. .
 
10.
Manger K, Kusus M, Forster C, et al. Factors associated with coronary artery calcification in young female patients with SLE. Ann Rheum Dis 2003; 62: 846-850. .
 
11.
Svenungsson E, Jensen-Urstad K, Heimburger M, et al. Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 2001; 104: 1887-1893. .
 
12.
Urowitz M, Gladman D. Accelerated atheroma in lupus - background. Lupus 2000; 9: 161-165. .
 
13.
Leong K, Koh E, Feng P, et al. Lipid profiles in patients with systemic lupus erythematosous. J Rheumatol 1994; 21: 1264-1267. .
 
14.
Sari R, Polat M, Taysi S, et al. Serum lipoprotein(a) level and its clinical significance in patients with systemic lupus erythematosous. Clin Rheumatol 2002; 21: 520-524. .
 
15.
Frostegard J. Systemic lupus erythematosus and cardiovascular disease. Lupus 2008; 17: 364-367. .
 
16.
Child D, Hudson P, Hunter-Lavin C, et al. Birth defects and anti-heat shock protein 70 antibodies in early pregnancy. Cell Stress Chaperones 2006; 11: 101-105. .
 
17.
Doria A, Shoenfeld Y, Wu R, et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 2003; 62: 1071-1077.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top